Published in Support Care Cancer on February 12, 2013
Cancer pain management in an oncological ward in a comprehensive cancer center with an established palliative care unit. Support Care Cancer (2013) 0.77
Clinical Usefulness of Hydromorphone-OROS in Improving Sleep Disturbances in Korean Cancer Patients: A Multicenter, Prospective, Open-Label Study. Cancer Res Treat (2014) 0.77
The effects of alcoholism and smoking on advanced cancer patients admitted to an acute supportive/palliative care unit. Support Care Cancer (2017) 0.75
Prevalence of pain in patients with cancer: a systematic review of the past 40 years. Ann Oncol (2007) 6.35
Prevalence of undertreatment in cancer pain. A review of published literature. Ann Oncol (2008) 4.70
A high-volume specialist palliative care unit and team may reduce in-hospital end-of-life care costs. J Palliat Med (2003) 2.93
Opioid purchases and expenditure in nine western European countries: 'are we killing off morphine?'. Palliat Med (2005) 2.32
Integrating supportive and palliative care in the trajectory of cancer: establishing goals and models of care. J Clin Oncol (2010) 1.87
Pain treatment and outcomes for patients with advanced cancer who receive follow-up care at home. Cancer (1999) 1.77
Pain and pain treatments in European palliative care units. A cross sectional survey from the European Association for Palliative Care Research Network. Palliat Med (2005) 1.75
High dose morphine use in the hospice setting. A database survey of patient characteristics and effect on life expectancy. Cancer (1999) 1.68
Development and implementation of an inpatient acute palliative care service. J Palliat Med (2002) 1.58
Palliative care inpatient service in a comprehensive cancer center: clinical and financial outcomes. J Clin Oncol (2004) 1.55
Pattern and quality of care of cancer pain management. Results from the Cancer Pain Outcome Research Study Group. Br J Cancer (2009) 1.37
Prevalence and management of pain in Italian patients with advanced non-small-cell lung cancer. Br J Cancer (2004) 1.20
Palliative care in advanced cancer patients: how and when? Oncologist (2012) 1.16
Patterns of high-dose morphine use in a home-care hospice service: should we be afraid of it? Cancer (2004) 1.14
World Health Organization guidelines for cancer pain: a reappraisal. Ann Oncol (2005) 1.12
Intravenous morphine for management of cancer pain. Lancet Oncol (2010) 1.03
The use of rapid onset opioids for breakthrough cancer pain: the challenge of its dosing. Crit Rev Oncol Hematol (2011) 1.02
Frequency, indications, outcomes, and predictive factors of opioid switching in an acute palliative care unit. J Pain Symptom Manage (2009) 1.00
A model of acute symptom control unit: Pain Relief and Palliative Care Unit of La Maddalena Cancer Center. Support Care Cancer (2002) 0.96
Pain and its treatment in hospitalized patients with metastatic cancer. Support Care Cancer (2003) 0.95
Achievement of personalized pain goal in cancer patients referred to a supportive care clinic at a comprehensive cancer center. Cancer (2011) 0.94
Transmucosal fentanyl vs intravenous morphine in doses proportional to basal opioid regimen for episodic-breakthrough pain. Br J Cancer (2007) 0.94
Home palliative care for terminal cancer patients: a survey on the final week of life. Palliat Med (1999) 0.94
Acute inpatient palliative medicine in a cancer center: clinical problems and medical interventions--a prospective study. Am J Hosp Palliat Care (2007) 0.93
Opioid prescription for terminally ill outpatients in a district of northern Italy: a retrospective survey. Pharmacol Res (2003) 0.92
Palliative care units: the best option for the most distressed. Arch Intern Med (2011) 0.88
Pattern and characteristics of advanced cancer patients admitted to hospices in Italy. Support Care Cancer (2012) 0.87
Palliative care in Italy: problem areas emerging from the literature. Minerva Anestesiol (2010) 0.86
Prevalence and treatment of cancer pain in Italian oncological wards centres: a cross-sectional survey. Support Care Cancer (2008) 0.86
Breakthrough pain in advanced cancer patients followed at home: a longitudinal study. J Pain Symptom Manage (2009) 0.86
Pain experienced by patients hospitalized at the National Cancer Institute of Milan: research project "towards a pain-free hospital". Tumori (2000) 0.85
Impact of opening an acute palliative care unit on administrative outcomes for a general oncology ward. Cancer (2008) 0.85
An Italian survey on the attitudes in treating breakthrough cancer pain in hospice. Support Care Cancer (2010) 0.84
The use of opioids for breakthrough pain in acute palliative care unit by using doses proportional to opioid basal regimen. Clin J Pain (2010) 0.84
An observational study of oncology patients' utilization of breakthrough pain medication. J Pain Symptom Manage (2008) 0.84
Clinical and financial analysis of an acute palliative care unit in an oncological department. Palliat Med (2008) 0.84
Breakthrough pain in oncology: a longitudinal study. J Pain Symptom Manage (2010) 0.83
Investigation of an opioid response categorization in advanced cancer patients. J Pain Symptom Manage (1999) 0.82
Outcome of opioid switching 4 weeks after discharge from a palliative care unit. Curr Med Res Opin (2011) 0.80
High-dose oral morphine in cancer pain management: a report of twelve cases. J Clin Anesth (1996) 0.77
Problematic discharge from hospital for patients prescribed opioids for cancer pain. J Pain Symptom Manage (2005) 0.75
The financial benefits of acute inpatient palliative medicine: an inter-institutional comparative analysis by all patient refined-diagnosis related group and case mix index. J Support Oncol (2005) 0.75
Botulinum toxin type A in the treatment of sialorrhea in Parkinson's disease. J Am Geriatr Soc (2008) 2.05
A five-year retrospective study of the epidemiological characteristics and visual outcomes of patients hospitalized for ocular trauma in a Mediterranean area. BMC Ophthalmol (2008) 1.49
Evaluation of esophageal motility using multichannel intraluminal impedance in healthy children and children with gastroesophageal reflux. J Pediatr Gastroenterol Nutr (2011) 1.49
The use of sublingual fentanyl for breakthrough pain by using doses proportional to opioid basal regimen. Curr Med Res Opin (2013) 1.47
Efficacy of periportal infiltration and intraperitoneal instillation of ropivacaine after laparoscopic surgery in children. J Laparoendosc Adv Surg Tech A (2009) 1.43
Short-term effects of high-intensity laser therapy versus ultrasound therapy in the treatment of people with subacromial impingement syndrome: a randomized clinical trial. Phys Ther (2009) 1.35
One-year outcomes with new-generation multifocal intraocular lenses. Ophthalmology (2008) 1.35
Deep sclerectomy versus punch trabeculectomy with or without phacoemulsification: a randomized clinical trial. J Glaucoma (2004) 1.16
Lifestyle-related factors in predementia and dementia syndromes. Expert Rev Neurother (2008) 1.06
Sustained-release oral morphine versus transdermal fentanyl and oral methadone in cancer pain management. Eur J Pain (2008) 1.04
Single nucleotide polymorphisms (SNPs) of pro-inflammatory/anti-inflammatory and thrombotic/fibrinolytic genes in patients with acute ischemic stroke in relation to TOAST subtype. Cytokine (2012) 1.04
Sleep disorders in advanced cancer patients: prevalence and factors associated. Support Care Cancer (2004) 1.03
KPC - 3 Klebsiella pneumoniae ST258 clone infection in postoperative abdominal surgery patients in an intensive care setting: analysis of a case series of 30 patients. BMC Anesthesiol (2013) 1.03
Deep sclerectomy versus trabeculectomy with low-dosage mitomycin C: four-year follow-up. Ophthalmologica (2008) 1.01
Surveillance of multidrug-resistant gram-negative bacilli in a neonatal intensive care unit: prominent role of cross transmission. Am J Infect Control (2007) 1.01
Frequency, indications, outcomes, and predictive factors of opioid switching in an acute palliative care unit. J Pain Symptom Manage (2009) 1.00
Is ranibizumab effective in stopping the loss of vision for choroidal neovascularisation in pathologic myopia? A long-term follow-up study. Br J Ophthalmol (2010) 0.99
Addition of a second opioid may improve opioid response in cancer pain: preliminary data. Support Care Cancer (2004) 0.98
Optimization of opioid therapy for preventing incident pain associated with bone metastases. J Pain Symptom Manage (2004) 0.97
The use of high doses of oxycodone in an acute palliative care unit. Am J Hosp Palliat Care (2010) 0.96
Medical treatment for inoperable malignant bowel obstruction: a qualitative systematic review. J Pain Symptom Manage (2007) 0.95
Opioid escalation in patients with cancer pain: the effect of age. J Pain Symptom Manage (2006) 0.95
Acoustic analysis of swallowing sounds: a new technique for assessing dysphagia. J Rehabil Med (2009) 0.93
Cryptic Leishmania infantum infection in Italian HIV infected patients. BMC Infect Dis (2009) 0.93
Immuno-inflammatory predictors of stroke at follow-up in patients with chronic non-valvular atrial fibrillation (NVAF). Clin Sci (Lond) (2009) 0.92
Controlled sedation for refractory symptoms in dying patients. J Pain Symptom Manage (2008) 0.91
Tapentadol in cancer pain management: a prospective open-label study. Curr Med Res Opin (2012) 0.91
SBOTE study: extracorporeal shock wave therapy versus electrical stimulation after botulinum toxin type a injection for post-stroke spasticity-a prospective randomized trial. Ultrasound Med Biol (2012) 0.90
E-PTFE (Gore-Tex) implant with or without low-dosage mitomycin-C as an adjuvant in penetrating glaucoma surgery: 2 year randomized clinical trial. Acta Ophthalmol (2007) 0.90
Safety and effectiveness of intravenous morphine for episodic (breakthrough) pain using a fixed ratio with the oral daily morphine dose. J Pain Symptom Manage (2004) 0.90
Patients' and relatives' perceptions about intravenous and subcutaneous hydration. J Pain Symptom Manage (2005) 0.89
Combined oral prolonged-release oxycodone and naloxone in chronic pain management. Expert Opin Investig Drugs (2012) 0.89
Assessment of treatment response in hepatocellular carcinoma: a review of the literature. Future Oncol (2013) 0.88
Safety and effectiveness of intravenous morphine for episodic breakthrough pain in patients receiving transdermal buprenorphine. J Pain Symptom Manage (2006) 0.87
Opioid-induced or pain relief-reduced symptoms in advanced cancer patients? Eur J Pain (2006) 0.87
Peripheral frequency of CD4+ CD28- cells in acute ischemic stroke: relationship with stroke subtype and severity markers. Medicine (Baltimore) (2015) 0.87
Deep sclerectomy versus punch trabeculectomy: effect of low-dosage mitomycin C. Ophthalmologica (2005) 0.87
Extensor deficiency: first cause of childhood flexible flat foot. Orthopedics (2009) 0.87
Rapid titration with intravenous morphine for severe cancer pain and immediate oral conversion. Cancer (2002) 0.87
Opioid switching from and to tapentadol extended release in cancer patients: conversion ratio with other opioids. Curr Med Res Opin (2013) 0.87
Pattern and characteristics of advanced cancer patients admitted to hospices in Italy. Support Care Cancer (2012) 0.87
Dosing fentanyl buccal tablet for breakthrough cancer pain: dose titration versus proportional doses. Curr Med Res Opin (2012) 0.86
Treatment of hepatocellular carcinoma: present and future. Expert Rev Anticancer Ther (2013) 0.86
How do cancer patients receiving palliative care at home die? A descriptive study. J Pain Symptom Manage (2011) 0.86
Incidence of chronic pain in patients with end-stage renal disease on dialysis. J Pain Symptom Manage (2005) 0.86
Breakthrough pain in advanced cancer patients followed at home: a longitudinal study. J Pain Symptom Manage (2009) 0.86
Switching from transdermal drugs: an observational "N of 1" study of fentanyl and buprenorphine. J Pain Symptom Manage (2007) 0.86
Effects of red blood cell transfusion on anemia-related symptoms in patients with cancer. J Palliat Med (2009) 0.85
Effectiveness of the frequency rhythmic electrical modulation system for the treatment of chronic and painful venous leg ulcers in older adults. Rejuvenation Res (2012) 0.85
Rapid switching between transdermal fentanyl and methadone in cancer patients. J Clin Oncol (2005) 0.84
Effectiveness of botulinum toxin type A treatment of neck pain related to nocturnal bruxism: a case report. J Chiropr Med (2010) 0.84
Emergencies in patients with advanced cancer followed at home. J Pain Symptom Manage (2012) 0.84
Celiac plexus block for pancreatic cancer pain: factors influencing pain, symptoms and quality of life. J Pain Symptom Manage (2003) 0.84
Morphine versus oxycodone in pancreatic cancer pain: a randomized controlled study. Clin J Pain (2010) 0.84
Opioid switching in patients with advanced cancer followed at home. A retrospective analysis. J Pain Symptom Manage (2012) 0.84
An Italian survey on the attitudes in treating breakthrough cancer pain in hospice. Support Care Cancer (2010) 0.84
The use of opioids for breakthrough pain in acute palliative care unit by using doses proportional to opioid basal regimen. Clin J Pain (2010) 0.84
Fentanyl buccal tablets for breakthrough pain in highly tolerant cancer patients: preliminary data on the proportionality between breakthrough pain dose and background dose. J Pain Symptom Manage (2011) 0.84
Breakthrough pain in oncology: a longitudinal study. J Pain Symptom Manage (2010) 0.83
Prognostic factors of survival in patients with advanced cancer admitted to home care. J Pain Symptom Manage (2012) 0.83
Evaluation of esophageal motility and reflux in children treated for esophageal atresia with the use of combined multichannel intraluminal impedance and pH monitoring. J Pediatr Surg (2011) 0.83
Botulinum toxin type A and a rehabilitation program in the treatment of Pisa syndrome in Parkinson's disease. J Neurol (2010) 0.83
Low doses of transdermal buprenorphine in opioid-naive patients with cancer pain: a 4-week, nonrandomized, open-label, uncontrolled observational study. Clin Ther (2009) 0.83
Vestibular Implants: 8 Years of Experience with Electrical Stimulation of the Vestibular Nerve in 11 Patients with Bilateral Vestibular Loss. ORL J Otorhinolaryngol Relat Spec (2015) 0.83
Effectiveness of switching therapy from complexing protein-containing botulinum toxin type A to a formulation with low immunogenicity in spasticity after stroke: a case report. J Rehabil Med (2012) 0.82
Clinical research in Italy in adult patients unable to consent: after implementation of the European Union's Directive 2001/20/CE. Intensive Care Med (2006) 0.82
Tools for identifying cancer pain of predominantly neuropathic origin and opioid responsiveness in cancer patients. J Pain (2009) 0.82
Gastroesophageal reflux in young children treated for esophageal atresia: evaluation with pH-multichannel intraluminal impedance. J Pediatr Gastroenterol Nutr (2011) 0.82
The risk of recurrent cardiovascular events in patients with increased plasma homocysteine levels is reduced by short but not long-term therapy with folate and B vitamins. Thromb Res (2007) 0.81
Meaningful cut-off pain intensity for breakthrough pain changes in advanced cancer patients. Curr Med Res Opin (2012) 0.81
Tapentadol at medium to high doses in patients previously receiving strong opioids for the management of cancer pain. Curr Med Res Opin (2014) 0.81
Outcome of opioid switching 4 weeks after discharge from a palliative care unit. Curr Med Res Opin (2011) 0.80
Relationship between background cancer pain, breakthrough pain, and analgesic treatment: a preliminary study for a better interpretation of epidemiological and clinical studies. Curr Med Res Opin (2013) 0.80
Factors involved in gastrointestinal bleeding in advanced cancer patients followed at home. Support Care Cancer (2003) 0.80
Investigation and management of Toxoplasma gondii infection in pregnancy and infancy: a prospective study. Acta Pharmacol Sin (2011) 0.80
Food safety in hospital: knowledge, attitudes and practices of nursing staff of two hospitals in Sicily, Italy. BMC Health Serv Res (2007) 0.80
Palliative sedation in advanced cancer patients followed at home: a retrospective analysis. J Pain Symptom Manage (2012) 0.80
US Food and Drug Administration's Risk Evaluation and Mitigation Strategy for extended-release and long-acting opioids: pros and cons, and a European perspective. Drugs (2012) 0.79
Efficacy and safety of higher doses of botulinum toxin type A NT 201 free from complexing proteins in the upper and lower limb spasticity after stroke. J Neural Transm (Vienna) (2012) 0.79
Electronic baropodometry in patients affected by ocular torticollis. Strabismus (2011) 0.79
Does pain intensity predict a poor opioid response in cancer patients? Eur J Cancer (2011) 0.79
A prospective randomized study of corticosteroids as adjuvant drugs to opioids in advanced cancer patients. Am J Hosp Palliat Care (2007) 0.79
Pain mechanisms involved and outcome in advanced cancer patients with possible indications for celiac plexus block and superior hypogastric plexus block. Tumori (2002) 0.79
The effects of low doses of pregabalin on morphine analgesia in advanced cancer patients. Clin J Pain (2013) 0.78
Effect of intrathecal baclofen, botulinum toxin type A and a rehabilitation programme on locomotor function after spinal cord injury: a case report. J Rehabil Med (2010) 0.78
Residual vein thrombosis for assessing duration of anticoagulation after unprovoked deep vein thrombosis of the lower limbs: the extended DACUS study. Am J Hematol (2011) 0.78
Nosocomial colonization due to imipenem-resistant Pseudomonas aeruginosa epidemiologically linked to breast milk feeding in a neonatal intensive care unit. Acta Pharmacol Sin (2008) 0.78
Pain intensity as prognostic factor in cancer pain management. Pain Pract (2014) 0.78
The use of fentanyl buccal tablets for breakthrough pain by using doses proportional to opioid basal regimen in a home care setting. Support Care Cancer (2013) 0.77
Amitriptyline in neuropathic cancer pain in patients on morphine therapy: a randomized placebo-controlled, double-blind crossover study. Tumori (2002) 0.77
Lymphocyte apoptosis in children with central nervous system tuberculosis: a case control study. BMC Pediatr (2011) 0.77
Botulinum toxin type A in the treatment of painful adductor muscle contracture after total hip arthroplasty. Orthopedics (2009) 0.77
Equipotent doses to switch from high doses of opioids to transdermal buprenorphine. Support Care Cancer (2008) 0.77
Cancer pain management in an oncological ward in a comprehensive cancer center with an established palliative care unit. Support Care Cancer (2013) 0.77